Edition:
United Kingdom

Advaxis Inc (ADXS.OQ)

ADXS.OQ on NASDAQ Stock Exchange Global Select Market

0.40USD
23 Aug 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$0.40
Open
$0.44
Day's High
$0.44
Day's Low
$0.40
Volume
140,279
Avg. Vol
97,370
52-wk High
$23.70
52-wk Low
$0.36

About

Advaxis, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant... (more)

Overall

Beta: 2.03
Market Cap(Mil.): $187.67
Shares Outstanding(Mil.): 41.07
Dividend: --
Yield (%): --

Financials

  ADXS.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -2.29 -- --
ROI: -105.74 8.95 14.48
ROE: -116.33 10.09 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates